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Human keratinocyte motility plays an important role
in the re-epithelialization of human skin wounds. The
wound bed over which human keratinocytes migrate
is rich in extracellular matrices, such as ®brin, ®bro-
nectin, and collagen, and serum factors, such as plate-
let-derived growth factor and transforming growth
factor b1. Extracellular matrices and the serum
factors bind to cell surface receptors and initiate a
cascade of intracellular signaling events that regulate
cell migration. In this study, we identi®ed an intra-
cellular signaling pathway that mediates collagen-
driven motility of human keratinocytes. Pharmaco-
logic inhibition of the activation of p38-a and p38-b
mitogen-activated protein kinase activation potently
blocked collagen-driven human keratinocyte migra-
tion. Transfection of the same keratinocytes with
the kinase-negative mutants of p38-a or p38-b
mitogen-activated protein kinase markedly inhibited
keratinocyte migration on collagen. Attachment of
keratinocytes to collagen activated p38 mitogen-
activated protein kinase, as well as p44/p42 ERKs.
Interestingly, activation of the p38 mitogen-activated
protein kinase cascade by overexpressing the consti-
tutively active MKK3 and MKK6, MKK3b(E) and
MKK6b(E), could neither initiate migration in the
absence of collagen nor enhance collagen-driven
migration. This study provides evidence that the p38-
MAPK/SAPK pathway is necessary, but insuf®cient,
for mediating human keratinocyte migration on col-
lagen. Key words: extracellular matrix/keratinocytes/p38-
MAPK/motility/signal transduction. J Invest Dermatol
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ound healing is a complex process requiring the
collaborative efforts of multiple tissues and cell
lineages. The events in healing cutaneous
wounds include clotting of blood components,
in¯ammation, granulation tissue formation,
re-epithelialization, angiogenesis, ®broplasia, and connective tissue
retraction (Gailit and Clark, 1994). The epidermis of human skin is
composed mainly of keratinocytes, whose migration and prolifera-
tion play an important role in the re-epithelialization of skin
wounds. In response to an acute wound, the basal keratinocytes at
the margins of the wound and within cut appendages enter a
migratory mode and laterally migrate across the provisional wound
bed to resurface the wound (Woodley, 1996; Martin, 1997). These
cellular events of human keratinocytes (HK) are regulated by both
soluble serum factors and extracellular matrix (ECM) components
within the microenvironment of the wound. There is evidence that
selective growth factors, cytokines, and ECM components promote
HK migration (Woodley, 1996). Although many serum factors
have both mitogenic and motogenic effects on cells, HK cell
division and migration are apparently controlled by independent
intracellular signaling mechanisms. Sarret et al showed that
transforming growth factor b1 (TGF-b1) markedly inhibited the
proliferation of HK but did not inhibit cell motility (Sarret et al,
1992). The presence of mitomycin C inhibits keratinocyte
proliferation but does not affect cell migration (Cha et al, 1996;
O'Toole et al, 1997). Furthermore, keratinocyte migration on
selected pro-motility ECMs, such as ®bronectin and collagen,
begins at 2±3 h in vitro, well before the G1 to S phase transition
(10±14 h) of cell division (> 25 h) takes place.
It has been well established that the Ras±MEKK±MEK±ERK
pathway, which can be activated by both growth factor receptors
and ECM receptors (integrins), regulates DNA synthesis and cell
proliferation. Our current understanding of the signaling pathways
that control HK motility, however, still remains fragmentary.
Yurko et al recently reported that, in highly migratory HK, focal
adhesion kinase (FAK) was heavily tyrosine phosphorylated
throughout the 18 h period of the migration assay. Antisense
oligonucleotides against FAK blocked HK migration on collagen
and ®bronectin (Yurko et al, 2001). Zeigler et al showed that
hepatocyte growth factor and epidermal growth factor stimulate
prolonged activation of ERKs and JNK in HK. Blockade of the
ERK activation by PD098059 inhibited hepatocyte-growth-factor-
stimulated cell migration and matrix metalloproteinase 9 (MMP-9)
production in HK (Zeigler et al, 1999). O'Toole and colleagues
showed that HK apposed to collagens or ®bronectin exhibited
increased motility when subjected to hypoxic conditions compared
with normoxic conditions. The increase in motility correlated with
increased expression and redistribution of the lamellipodia-associ-
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ated proteins (such as ezrin, radixin, and moesin) and enhanced
secretion of the 92 kDa type IV collagenase/MMP-9 (O'Toole et al,
1997). Although the signaling mechanism of the hypoxia-induced
HK motility remains unclear, activation of the p38-mitogen-
activated protein kinase (MAPK)/SAPK pathway under hypoxia
conditions has been reported in the neuronal cell line PC12
(Conrad et al, 1999). Moreover, in the transformed keratinocyte
cell line HaCaT, expression of MMP-13 and MMP-1 required the
activity of p38-MAPK (Johansson et al, 2000).
The p38-MAPK/SAPK2/RK family, including p38-a, p38-b,
p38-g, and p38-d (also known as SAPK2a, 2b, 3, and 4), represents
one of the three major families of MAPK cascades (Schaeffer and
Weber, 1999; Ono and Han, 2000). The other two include the
p42/p44 ERK and the JNK/SAPK pathways. The p38-MAPK
family members appear to have distinct tissue distributions. p38-a
and p38-b are widely expressed (Jiang et al, 1996; Stein et al, 1997).
p38-d was found to be widely expressed by one group (Wang et al,
1997), and more restrictedly expressed by another group (Jiang et al,
1997). p38-g appeared to be expressed mainly in skeletal muscle
(Lechner et al, 1996; Li et al, 1996). Furthermore, p38-a and p38-b
can be pharmacologically distinguished from p38-g and p38-d by
pyridinyl imidazole inhibitors such as FHPI/SB202190 and
SB203580. The kinase activity of p38-a and p38-b, but not p38-
g and p38-d, can be blocked in the cells in the presence of these
inhibitors (Lee et al, 1994; reviewed by Ono and Han, 2000). p38-
MAPKs are speci®cally phosphorylated and activated by the MAPK
kinases (MAPKK) MKK3 and MKK6 (DeÂrijard et al, 1995;
Raingeaud et al, 1996; Enslen et al, 1998), which do not affect
JNK and ERK activity. Further upstream activators include the
Rho family GTPases, Rac1 and Cdc42 (Mackay and Hall, 1998),
and the cytoplasmic kinase Pak1 (Bagrodia et al, 1995; Zhang et al,
1995).
p38-MAPKs were initially de®ned as the stress-activated protein
kinases in cells in response to stresses such as ultraviolet light,
osmotic stress, in¯ammatory cytokines, changes in oxygen content,
and inhibition of protein synthesis (Brewster et al, 1993; Han et al,
1994). Recent studies, however, found that p38-MAPKs are also
activated in response to a variety of extracellular growth and
differentiation cues (Nebreda and Porras, 2000), suggesting that the
p38-MAPK pathway is involved in a broad range of cellular
responses. In a search for the signaling pathways that mediate HK
migration on type I collagen, we screened a panel of chemical
inhibitors for known signaling proteins and found that inhibition of
the p38-MAPKs potently blocked keratinocyte migration on
collagen. In this study, we present pharmacologic and genetic
evidence that activation of the p38-MAPK pathway is required for
keratinocyte motility on collagen.
MATERIALS AND METHODS
Materials Primary HK were purchased from Clonetics (San Diego,
CA). Immortalized human keratinocytes (IKC) were established in our
laboratory (Chen et al, 2000). All primary and immortalized keratinocytes
were cultured in serum-free, low calcium medium supplemented with
bovine pituitary extract (BPE), as the source of growth factors. Native
rat tail type I collagen was purchased from Collaborative Biomedical
Products (Bedford, MA). Anti-p38-MAPK (C-20) and anti-phospho-
p38-MAPK (pThr180/pTyr182) antibodies were purchased from New
England Biolabs (Beverly, MA). Anti-phospho-JNK antibody (G-7) was
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-p44/
p42-MAPK antibody (E10) was from New England Biolabs. The p38-
MAPK's upstream activators, MKK3b(E) and MKK6b(E), in pCDNA3
were from J. Han's group and used as previously described (Jiang et al,
1996). The green ¯uorescent protein (GFP) gene pCDNA3 construct
was from Gibco BRL (Gaithersburg, MD). Gold chloride was from
Sigma (St. Louis, MO). OPTI-MEM Reduced Serum Medium and
lipofectamine reagent were purchased from Gibco BRL. The chemical
inhibitors (vide infra) were purchased from Calbiochem (La Jolla, CA)
and Sigma.
List of signaling pathway inhibitors used and pretreatment
conditions A panel of chemical inhibitors and their experimental
concentrations were selected for our studies following preliminary studies
designed to examine their cytotoxic effects on HK. Cytotoxicity of these
chemicals was examined by using a Trypan blue staining exclusion assay
and a cell proliferation assay after drug withdrawal, as modi®ed by Nasca
et al (1999). Our criterion for the Trypan blue exclusion assay was that,
after exposure to the agent, more than 90% of the cells excluded the
Trypan blue dye. The second criterion for the lack of cytotoxicity was
that, after exposure to the agent and its subsequent withdrawal, the cells
were able to proliferate and double in culture at or above the 90% level
of control unexposed cells. The inhibitors listed in Table I passed the
cytotoxicity screening criteria. It should be pointed out that the effective
concentrations of many of these inhibitors for cultured cells are much
higher than their listed IC50 values, as the latter were often obtained by
using puri®ed proteins. The exposure times used for each agent were
based on standard published exposure times, as previously described (Dey
et al, 2000). In contrast to the agents listed in Table I, some other
commercially available inhibitors, such as Rho family GTPase inhibitor
C. dif®cile Toxin B and glycogen synthase kinase (GSK-3-b) inhibitor
Li+, showed signi®cantly toxic effects in keratinocytes and therefore
were excluded from the studies. After determining their noncytotoxic
concentrations, the effects of the inhibitors on HK migration were
examined.
Cell culture and transfection HK cells were cultured in keratinocyte
growth medium (KGM; Clonetics, San Diego, CA) according to
previously established procedures (Boyce and Ham, 1983). Third or
fourth passages of the keratinocytes in culture were used for all
experiments. The IKC were maintained in standard-formulation, serum-
free growth medium for keratinocytes (SFM; Gibco BRL) supplemented
with epidermal growth factor and BPE as supplied by the vendor. The
Table I. Effects of signal transduction pathway inhibitors on human keratinocyte migration
Inhibitors IC50 Pretreatment time Targets Inhibition of migration
FTI-277 100 nM 24±28 h H-Ras, N-ras no
GGTI-298 1 mM 24±28 h K-Ras no
PP1 5 mM 12±24 h Src yesa
Rottlerin 3±6 mM 60 min PKCd yesa
HA-1004 3±13 mM 15±25 min PKA/CaMKII no
Wortmannin 0.5 mM 15 min PI-3K no
LY294002 1.4 mM 30 min PI-3K no
PD98059 5±30 mM 15 min MEK1 no
cycloheximide 10 mM 30 min translation yesa
SB-203580 0.24 mM 10 min p38-MAPK yesa
SB-202190 0.35 mM 30 min p38-MAPK yesa
Rapamacin 1 mM 30 min p70S6K no
Tyrphostin 7.5 mM 25 min PTK yes
aReduction of >30% in MI was taken as signi®cant inhibition. All reactions were measured within the ®rst 6 h after plating HK cells on collagen matrix.
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human squamous carcinoma cell line, A431, was maintained in
Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal
bovine serum.
Cells were plated 1 d prior to transfection in six-well plates and
reached 40%±60% con¯uence following overnight culture.
Transfection was carried out by using lipofectAMINE, according to
the manufacturer's instructions. We consistently observed a 15%±30%
transfection ef®ciency. A pCDNA3 construct with GFP gene was
cotransfected with the DNA samples, in order to distinguish
transfected cells from nontransfected cells. The GFP-positive cells
were separated by ¯uorescence-activated cell sorter (FACS) analysis
and then subjected to the migration experiments.
Cell motility colloidal gold phagokinetic assay Cell migration on
collagen was examined by using the phagokinetic track assay, as
previously described by Albrecht-Buehler (1977) and modi®ed by
Woodley et al (1988) for computer-assisted analysis. Brie¯y, coverslips
(35 mm in diameter) were dipped in 1% freshly prepared bovine
serum albumin (BSA) in phosphate-buffered saline (PBS) and then in
100% ethanol and were quickly dried with a hair dryer. They were
placed into 12-well tissue culture plates, one coverslip per well. Gold
salt solution (9% of gold salt is combined with 52% of H2O and
30% of the Na2CO3 solution) was heated in an Erlenmeyer ¯ask
with constant swirling until boiling and then removed from the heat
source. An equal volume of freshly prepared formaldehyde (0.1%)
was slowly added to the gold salt mixture with swirling. The
mixture turned purple-brown and was immediately pipetted into the
12-well plates with BSA-coated coverslips at 1 ml per well. The
plates were covered and left undisturbed for 1±2 h to let the gold
salt particles settle. Following removal of the gold salt solution, the
coverslips were gently rinsed once with 1 ml of Hank's buffered salt
solution (HBSS) and then incubated with 1 ml of HBSS containing
5 mM Ca2+ and 15±30 mg per ml type I collagen at 37°C for 2 h.
The collagen solution was removed and plates were rinsed once with
HBSS without Ca2+ prior to plating the cells and the control cell
lines. Cells were trypsinized, resuspended in proper medium, and
counted. Approximately 3000 cells were plated onto the coverslips
and allowed to migrate for different periods of time. The medium
was removed and cells were ®xed in 0.1% formaldehyde in PBS for
10 min. Migration was examined under dark ®eld optics and
photographed. Fifteen randomly selected and nonoverlapping ®elds
under each experimental condition were analyzed with an attached
CCD camera (Model KP-MIU, Hitachi-Denshi) and a computer
using the NIH Image 1.6 program, which calculates migration index
(MI). The MI represents the percentage of the total ®eld area
viewed by the microscope that is consumed by cell migration tracks.
Statistical analysis The methodology to determine if the difference in
MIs between experimental sets of migrating keratinocytes exists has
previously been published (Chen et al, 1993). In brief, statistical analyses
of differences in MIs between triplicate sets of experimental conditions
were performed using Microsoft Excel. Con®rmation of a difference in
migration as statistically signi®cant requires rejection of the null
hypothesis of no difference between mean MIs obtained from replicate
sets at the p = 0.05 level with the Student t test (Chen et al, 1993).
Activation of p38-MAPK, p44/p42 ERK, and JNK HK, starved in
growth-factor-free medium overnight, were incubated in tissue culture
dishes precoated with either polylysine (10 mg per ml) or type I collagen
(coating conditions: 30 mg per ml, 2 h at 37°C) at 37°C for different
periods of time (more than 80% of the cells became attached to the
polylysine-coated dishes and more than 90% of the cells to the collagen-
coated dishes after 45 min). Cells were solubilized in lysis buffer as
previously described (Li et al, 1991), and the cell extracts were subjected
to Western immunoblotting analyses using either anti-phospho-p38-
MAPK antibody (Thr180/Tyr182, 1:150), which speci®cally recognizes
the activated forms of p38-MAPKs, or anti-p38-MAPK antibody (C-20,
1:1000), which recognizes both active and inactive forms of p38-
MAPKs. The latter was used as the control for equal loadings. To
examine p44/p42 ERK and JNK activation under similar conditions,
duplicate membranes were blotted with either anti-phospho-p44/p42
ERK antibodies (E10) or anti-phospho-JNK antibodies (G-7). For these
experiments, equal amounts of cell extract (»50 mg of total proteins)
were resolved on a sodium dodecyl sulfate gel, transferred to a nitro-
cellulose membrane, and immunoblotted with corresponding antibodies.
The results were visualized by a horseradish-peroxidase-conjugated
secondary antibody followed by enhanced chemiluminescence
(Amersham, Arlington Heights, IL).
RESULTS
Time course of HK migration on type I collagen To begin
the study of the mechanisms of keratinocyte migration, we set out
to examine the time course of HK migration on collagen to identify
the initiation of motility and maximal motility during the course of
our 18±22 h colloidal gold phagokinetic assay. Figure 1 shows that
following attachment of the cells to collagen, migration began at
approximately 2 h and reached maximal around 6 h (panels B±E),
when visualized under a dark ®eld microscope. The keratinocytes
produced long linear tracks. In contrast, no linear tracks were
observed without a collagen substratum either at the 2 h (panel A)
or 18 h (panel F) time point. During the time period of the assays,
cell proliferation did not occur, as the doubling time of HK
cultured in this manner is between 28 and 33 h, and the presence of
mitomicyn C did not block the migration (data not shown). The
MIs, calculated by using the NIH Image 1.6 program with camera-
assisted computer for each condition (see Materials and Methods), are
shown beneath each representative image of cell migration. The
MIs increased from 3 6 0.7 to over 8 6 1.6 in the ®rst 2 h. By
6 h, cell migration had maximized with MIs of more than 30. This
level of MIs remained essentially at a plateau for the remaining
duration of the assay. The latter data suggested that the migration
had ceased before 18 h. Why the cells cease to migrate is not
understood.
As the timing for the initiation of migration was between early
(de novo protein synthesis independent) and delayed early (®rst
round of gene expression) signaling events, we asked the question
whether de novo protein synthesis is required prior to cell migration.
We found that pretreatment of the HK with cycloheximide
(10 mM) nulli®es HK motility (see Table I, as indicated by an
asterisk), indicating that even the initiation of migration requires
new gene expression.
Inhibition of p38-MAPK blocks HK migration on
collagen To investigate the intracellular signal transduction
following attachment of HK to and subsequent migration on
type I collagen, we started out by screening a panel of chemical
inhibitors that are known to inhibit speci®c intracellular signaling
pathways. We tested the effects of these inhibitors on the migration
of primary HK, the IKCs and the human squamous carcinoma cell
line, A431. In these experiments, cells were suspended in growth
media with or without inhibitors at concentrations initially tested
by Trypan blue exclusion and cell proliferation assays and shown
not to be cytotoxic to the cells (vide supra). The cells were then
subjected to the migration assays. We found that three of the 10
inhibitors tested, SB202190/SB203580, rottlerin, and PP1,
potently blocked cell migration on type I collagen without
compromising cell viability (Table I, as indicated by asterisks).
SB202190, rottlerin, and PP1 are known to inhibit the activation of
p38-MAPK, protein kinase C-d, and Src kinases, respectively. It
should be pointed out that the actual effective concentrations of the
listed inhibitors for cultured cells are much higher than their
reported IC50 values, which were often obtained from experiments
using puri®ed enzymes.
Here, we speci®cally studied the role of p38-MAPK in the
control of migration. As shown in Fig 2, SB202190, which inhibits
p38-MAPK/p38-MAPK-a and p38-MAPK-b, exhibited a potent
inhibitory effect on collagen-driven migration of all three cell types.
As shown in Fig 2(A), in the absence of collagen, none of the three
types of cells migrated (panels a, b, c), whereas in the presence of
collagen, all three types of cells made linear motility tracks (panels d,
e, f) (location of the cell inside each track is indicated by an asterisk).
Cells incubated in media containing increasing concentrations of
SB292190, however, lost their migratory ability on collagen in a
concentration-dependent fashion (panels g±r) and completely
stopped migrating in the presence of 10±30 mM of SB202190
(panels p, q, r).
To quantitate migration, the MIs were measured as previously
described (Materials and Methods). As shown in Fig 2(B), the MIs
for HK, IKCs, and A431 cells on collagen in the absence of
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SB202190 were 32 6 3, 34 6 2.7, and 9 6 4.1, respectively. The
increased migration of all three cell types on collagen, however,
was inhibited by SB202190 in a concentration-dependent manner,
consistent with the image results shown in Fig 2(A). These results
suggested that SB292190-sensitive p38-MAPKs (i.e., p38-a or
p38-b or both) were involved in the collagen-dependent signal
transduction leading to HK migration.
Recent studies reported that SB203580 hits multiple cellular
targets such as Raf-1 kinase, PI-3 kinase, ERKs, and JNK besides
p38-MAPK, suggesting that perhaps SB202190 may not be as
speci®c as initially thought (Hall-Jackson et al, 1999; Kalmes et al,
1999; Rosenberger et al, 1999; Lali et al, 2000). PI-3 kinase has
previously been shown to play an important role in the migration
of human mammary epithelial and mouse ®broblast cells (reviewed
by Hall, 1998). In our experiments, we used SB202190 and not
SB203580. Although there have been no reports of SB202190
hitting multiple cellular targets, we nevertheless examined whether
or not the inhibition of the cell migration by SB202190 could be
due to inhibition of PI-3 kinase. We found, however, that
treatment of HK with Wortmanin or LY294002, two potent PI-3
kinase inhibitors, had no signi®cant inhibitory effect on collagen-
driven HK migration (Table I). These studies suggested that the
observed inhibition of migration by SB202190 was less likely to be
due to nonspeci®c effects on other cellular targets, such as PI-3
kinase.
Dominant-negative p38-MAPKs blocked collagen-driven
HK migration To further study the speci®c role of p38-
MAPKs, we overexpressed dominant-negative (kinase-de®cient)
p38-a (p38-a-AF) or p38-b (p38-b-AF) genes in HK and tested
whether this would affect the collagen-driven migration. A GFP
gene construct was cotransfected with the p38-MAPK constructs to
identify the cells that were actually gene-transduced. These GFP-
expressing cells were isolated by FACS and subjected to migration
assays. As shown in Fig 3(A), in the absence of collagen neither the
cells with vector alone nor the p38-MAPK-transfected cells
migrated (panels a, c, e, g, i). In contrast, on a collagen matrix, the
cells migrated dramatically as previously observed (panel b). The
collagen-driven migration, however, was signi®cantly inhibited by
p38-a-AF (panel f vs panel b) and p38-b-AF (panel j vs panel b). In
contrast, their wild-type counterparts showed neither stimulatory
nor inhibitory effects on migration (panels d, h vs panel b).
Quantitation of these experiments is shown in Fig 3(B). The
vector-alone-transfected cells produced MIs in the range of 15±18.
We noticed that these MIs were signi®cantly less than for
untransfected cells (see Fig 2). We are not sure why cells
exhibited lower MIs after being subjected to transfection and
FACS analysis. Nonetheless, the MIs in the cells transfected with
p38-a-AF and p38-b-A were reduced dramatically to 3 or less.
These results suggested strongly that activation of p38-MAPK-a or
p38-MAPK-b or both is required for HK migration on collagen.
When the lysates of the total cells were subjected to
immunoblotting (Western) with anti-p38 antibodies (C-20), the
intensity of the transfected, HA-tagged p38-MAPK was approxi-
mately 5-fold greater than the endogenous p38-MAPK (data not
shown). Taking the 30% transfection ef®ciency into account, the
ratio between the exogenously expressed p38-MAPK and the
endogenous p38-MAPK in the transfected cells could be 15:1. To
Figure 1. Time course of HK migration on type I collagen. HK, cultured in KGM plus BPE in a tissue culture dish, were lifted off by
trypsinization, pelleted by centrifugation, resuspended, and counted by a hemocytometer. Approximately 3000 cells were seeded on each pre-prepared
either polylysine-coated (±) (panels A, F) or collagen-coated (+) (panels B±E) gold salt covered coverslips in KGM plus BPE. The incubation was
stopped at the indicated times by ®xing the cells with 0.1% formaldehyde in PBS and migration was analyzed. The MIs were measured as described in
Materials and Methods and are presented under each of the corresponding photographic images. Similar results were observed from three independent
experiments. Cells within migration tracks are indicated by arrowheads. Col., type I collagen.
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Figure 2. Inhibition of p38-MAPK activation blocked HK
migration on collagen. HK, IKC, and A431 cells in culture were
trypsinized, washed, and resuspended in complete KGM plus BPE
without or with the indicated concentrations of SB202190.
Approximately 3000 cells were plated on each gold salt coverslip in SFM
either collagen-coated (+) or polylysine-coated (±). The incubation was
stopped at 20 h by ®xation and cell migration was analyzed. (A)
Representative photographic images of the migration tracks under each
of the conditions indicated. The cell in each track is indicated by an
asterisk. (B) Quantitation of the migration was measured by MIs
(Materials and Methods). Similar results were obtained from three
independent experiments.
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Figure 3. Dominant-negative p38-MAPK genes inhibit HK
migration on collagen. (A, B), HK (40% con¯uence in 6 cm dishes)
were transfected with vector alone, wild-type p38-a, p38-a-AF, wild-
type p38-b, or p38-b-AF (7 mg per dish) together with a pCDNA3-GFP
construct (3 mg per dish). The GFP-positive cells were sorted out from
rest of the cells by FACS analysis, and approximately 3000 cells were
seeded on either polylysine-coated (± collagen) or collagen-coated (+
collagen) gold salt coverslips in complete KGM plus BPE. Cells were
®xed for 20 h and migration was measured as described (Materials and
Methods). (A) Photographic images of representative migration tracks
under each condition; (B) quantitation of the migration by measuring the
MIs; (C) various DNA concentrations of the constructs were tested and
dose-dependent inhibition of the migration was observed.
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determine if there was a dose effect, we transfected HK with a
ladder of DNA concentrations to examine whether the inhibition
correlated with increased levels of p38-AF expression. As shown in
Fig 3(C), increasing concentrations of the wild-type p38-a-
MAPK or the wild-type p38-b-MAPK cDNA did not affect
collagen-induced cell migration. In contrast, increasing concentra-
tions of p38-a-AF or p38-b-AF cDNA inhibited migration in a
concentration-dependent manner (hatched bars). These results
further supported the ®nding that p38-MAPK (p38-a or p38-b
or both) are involved in the signaling of HK by a collagen matrix
that leads to cell migration.
Activation of p38-MAPK in migratory HK We then tested
whether or not p38-MAPKs were activated under the conditions of
our migratory assay (i.e., ECM plus growth factors). Subcon¯uent
cells in culture were deprived of growth factors (which could cause
by themselves activation of p38-MAPK) for 18 h, resuspended by
trypsinization, and then seeded on either collagen-coated or
polylysine-coated tissue culture plates for different periods of time
in the absence or presence of growth factors (i.e., BPE) (1 h was
chosen as the earliest time point, because the majority of cells
became attached after 45 min). Equal amounts of cell lysates were
subjected to Western immunoblotting analysis with anti-phospho-
p38-MAPK antibody. Duplicate samples were subjected to
immunoblotting with anti-phospho-p44/p42 ERK or anti-
phospho-JNK antibodies. Finally, anti-p38-MAPK antibody
blotting was used as the loading control. As shown in Fig 4(A),
cells apposed to polylysine had very low levels of phosphorylated
p38-MAPK (lanes 1, 3, 5, 7). In contrast, in the cells plated on
collagen in the presence of growth factors, p38-MAPK was
activated in a time-dependent fashion (lanes 2, 4, 6, 8). Similar
results were observed when duplicate samples were blotted with
anti-phospho-p44/p42 ERK antibody (Fig 4B). Activation of
both p44-ERK1 and p42-ERK2 was detected from the cells
apposed to collagen in the presence of complete medium (lanes 2,
4, 6, 8). In contrast, little activation of ERKs was observed in cells
on a polylysine substratum in the absence of growth factors (lanes 1,
3, 5, 7). There was no signi®cant activation of JNKs (p54 and p46)
in keratinocytes apposed to either polylysine or collagen (Fig 4C).
Equal loading of the gels was indicated by the similar amounts of
p38-MAPK proteins detected under the various conditions with
anti-p38-MAPK antibodies (Fig 4D). These results provided
biochemical evidence for the involvement of p38-MAPK in the
signal transduction events that occur when keratinocytes contact
collagen in the presence of growth factors and migration is initiated.
The importance of the ERK pathway in regulating HK motility
and MMP-9 production has previously been indicated (Zeigler et al,
1999).
Activation of p38-MAPK alone could not induce
motility An important question then was whether or not
activation of the p38-MAPK pathway alone is suf®cient to drive
cell migration in the absence of the collagen and growth factors, or
enhances the collagen-driven migration. To directly activate the
p38-MAPK pathway in the cells, we overexpressed two
constitutively active upstream activators of p38-MAPK, MKK3-
b(E) and MKK6-b(E) (DeÂrijard et al, 1995; Raingeaud et al, 1996;
Enslen et al, 1998), in HK together with the pCDNA3-GFP vector
as previously described. GFP-positive cells were isolated by FACS
analysis and subjected to colloidal gold phagokinetic assay. First, we
Figure 4. p38-MAPKs were activated in
migratory HK cells. HK cells were growth
factor (BPE) starved for 18 h, resuspended, and
seeded into dishes either polylysine-coated in the
absence of growth factors (±) or collagen-coated
in the complete medium (+) tissue and incubated
for the indicated times. (A) The lysates of the
cells were directly subjected to Western
immunoblotting analysis by using an anti-
phospho-p38-MAPK antibody (1:150). (B) A
duplicate membrane was blotted with an anti-
phospho-ERK antibody (1:600). (C) A duplicate
membrane was blotted with an anti-phospho-JNK
antibody (1:250). (D) A duplicate membrane was
blotted with an anti-p38-MAPK antibody to
indicate equl loading. Results were visualized
by a horseradish-peroxidase-conjugated secondary
antibody followed by enhanced chemi-
luminescence detection.
Figure 5. Expression MKK3b(E) and MKK6b(E) activates p38-
MAPKs in HK cells. HK cells were transfected with pCDNA-GFP,
pCDNA-MKK3(E), pCDNA-MKK6b(E), or MKK3b(E) plus
MKK6b(E) (Jiang et al, 1996). The lysates of the cells were subjected to
Western blot analysis with either anti-phospho-p38-MAPK antibody (A)
or anti-p38-MAPK antibody (B). Lysate of anisomycin-treated HK cells
was included as a positive control for the anti-phospho-p38-MAPK
antibody.
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tested whether or not the expression of the MKKs activated p38-
MAPK in the cells. It is shown in Fig 5 that activation of p38-
MAPK was not detected in the pCDNA3-vector-transfected cells
(panel A, lane 1). Dramatic activation of p38-MAPK, however, was
detected in cells transfected with pCDNA-MKK3b(E) (lane 2),
MKK6b(E) (lane 3), or MKK3b(E) plus MKK6b(E) (lane 4). Cell
lysate treated with anisomycin, a known activator of p38-MAPK,
was included as a positive control for anti-phospho-p38 antibodies
(lane 5). Similar amounts of p38-MAPK proteins were used for the
comparison (panel B).
Then, we studied if activation of p38-MAPK due to the
overexpression of the MKKs would drive cell migration in the
absence or presence of collagen and growth factors. As shown in
Fig 6(A), in the absence of collagen, cells transfected with
MKK3b(E), or MKK6b(E), or MKK3b(E) plus MKK6b(E) were
not able to migrate (panels C, E, G vs panel A). Further, activation
of p38-MAPK by MKKs did not enhance collagen-driven
migration (panels D, F, H vs panel B). Quantitation of the
experiments is shown in Fig 6(B). It can be seen that a similar
range of MIs under the various conditions was obtained via
computer analyses of the migration assays. This ®nding was further
con®rmed by the observation that the chemical p38-MAPK
activator, anisomycin (Hazzalin et al, 1999), had no signi®cant
effect on HK migration in the absence or presence of collagen,
Figure 6. Activation of p38-MAPKs by MKK3 and MKK6 alone
did not stimulate HK cell migration. HK cells in 6 cm tissue culture
dishes were transfected with pCDNA-GFP (10 mg), pCDNA-MKK3(E)
(7 mg plus 3 mg of GFP DNA), pCDNA-MKK6b(E) (7 mg plus 3 mg
of GFP DNA), or MKK3b(E) (5 mg) plus MKK6b(E) (5 mg) (plus 3 mg
of GFP DNA). After 48 h, GFP-positive cells were isolated by FACS
analysis and subjected to the migration assays. (A) Photographic images
of representative migration tracks under each condition; (B) quantitation
of the migration by measuring the MIs.
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even though anisomycin may have activated additional intracellular
signaling pathways (data not shown).
DISCUSSION
In the U.S.A. each year more than 1.25 million people suffer
from burns and 7 million have chronic skin ulcers from various
causes. It is estimated that almost $9 billion a year is spent on
wound care products in the U.S.A. alone. A better under-
standing of the mechanisms of skin wound healing and
strategies to jump-start the healing of chronic wounds would
therefore be a great advance for the care of patients. Although
wound healing is a complex event, the process of re-
epithelialization with the re-establishment of the skin's permea-
bility barrier, i.e., epidermis, is particularly critical. Keratinocyte
migration over components of the wound bed is an early and
essential step for re-epithelialization and wound closure
(Woodley, 1996; Martin, 1997; Singer and Clark, 1999). We
are interested in how keratinocytes are induced to transform
from a cell destined to differentiate and make a stratum
corneum to a highly migratory cell to cover a skin wound. In
this study, we demonstrated that the p38-MAPK pathway is
critical for collagen-driven keratinocyte migration. We found
that SB202190, a speci®c inhibitor of p38-a- and p38-b-
MAPKs, inhibited collagen-driven keratinocyte migration. To
con®rm this ®nding, we showed that overexpression of
dominant-negative p38-MAPKs (a and b) also blocked
collagen-driven keratinocyte migration. Interestingly, activation
of the p38-MAPK pathway alone was not suf®cient for
keratinocyte migration. Potent activation of p38-MAPK by
either overexpression of the upstream activators of p38-MAPK
pathway, MKK3 and MKK6, or anisomycin in the absence of
collagen could not induce keratinocyte migration. Further, the
activation of p38-MAPK activity could not augment the
collagen-driven keratinocyte motility above the collagen alone
condition. We conclude that the p38-MAPK pathway is
necessary but not suf®cient for mediating HK migration. We
speculate that other parallel pathways downstream of the
integrin receptor for collagen, as well as cytokine/growth factor
receptors, are simultaneously involved. During the preparation
and submission of this manuscript, Klekotka et al reported that
the a2 integrin subunit mediated migration on type I collagen
requires p38-MAPK in a transfected mouse mammary epithelial
cell line, NmuMG (Klekotka et al, 2001).
The functional relationship between different family members
of the p38-MAPK family in response to extracellular signals
remains elusive. Among the four p38-MAPK members (a, b, g,
and d), only a and b are sensitive to pyridinyl imidazole
inhibitors such as FHPI/SB202190 and SB203580. The inhib-
ition of migration by SB202190 suggests that either p38-a or
p38-b or both are involved in the signal transduction pathway
that leads to keratinocyte motility. Our dominant-negative p38-
MAPK gene experiments showed that overexpression of either
the kinase-defective p38-MAPK-a or the kinase-defective p38-
MAPK-b could inhibit cell migration. These results suggest two
possible mechanisms for the role of the p38-MAPK pathway.
One possibility is that both p38-MAPK-a and p38-MAPK-b
are required for mediating the migratory signal and each acts
independently. Therefore, inhibition of either one would block
the signal transduction. A second possibility is that only p38-
MAPK-a or p38-MAPK-b plays a direct role in migration, but
they share a common upstream activator(s). Overexpression of
either of the kinase-defective forms would compete for the
common upstream activator for both of the endogenous p38-
MAPK-a and p38-MAPK-b. The current understanding of the
mechanism by which p38-MAPKs are activated favors the latter
hypothesis, as no speci®c upstream activators or downstream
effectors for p38-MAPK-a or p38-MAPK-b have been
reported. To fully resolve this issue, we will need to have
inhibitors that can distinguish between p38-MAPK-a and p38-
MAPK-b, or carry out motility studies in p38-MAPK-a- and
p38-MAPK-b-de®cient keratinocytes.
The signaling mechanism by which binding of collagen to
the cell surface integrin receptor leads to activation of the p38-
MAPK cascade remains to be further studied. Mainiero et al
have recently shown that the guanine nucleotide exchange
factor vav and Rho family GTPase Rac mediate FN receptor/
b1 integrin-induced activation of p38-MAPK and subsequent
gene expression (Mainiero et al, 2000). They proposed that the
integrin-activated protein tyrosine kinases, such as FAK, and Src
phosphorylate and activate vav. Vav activates Rac, which in
turn stimulates the Pak/MKKK/MKK3/p38-MAPK pathway
(Mainiero et al, 2000). As type I collagen acts through binding
to the a2b1 integrin (Chen et al, 1993), it remains to be
determined whether or not the above signaling mechanism is
shared by the collagen/a2b1/p38-MAPK signaling in HK. In
addition to the role of p38-MAPK, the results of our initial
inhibitor screening experiments also implicated the involvement
of Src tyrosine kinase and PKC-d kinase. It is possible that
collagen activates the p38-MAPK pathway via activation of Src
kinase and then the Rho GTPases and PKC-d kinase. These
issues are beyond the scope of this paper, but experiments are
under way in our laboratory to study whether or not these
pathways act in a linear or parallel fashion.
How does the p38-MAPK pathway contribute to the
increased keratinocyte motility on collagen? One possible
mechanism is that the activation of this pathway increases
transcriptional activation of the genes whose products play
important roles in the control of cell motility. For instance, it is
known that secretion of metalloproteases by keratinocytes and
synthesis of lamellipodia-associated proteins (ezrin, radixin and
moesin) correlate with increased keratinocyte motility (O'Toole
et al, 1997; Pilcher et al, 1999). It is possible that the p38-
MAPK pathway mediates the collagen-induced secretion of
metalloproteases and/or increased synthesis of the lamellipodia-
associated proteins in keratinocytes. We have previously shown
that hypoxia enhances collagen- and ®bronectin-induced human
keratincyte migration by increasing the expression of lamellipo-
dia-associated proteins (ezrin, radixin, and moesin), increasing
the secretion of the 92 kDa type IV collagenase, and decreasing
the secretion of laminin-5 (O'Toole et al, 1997). Johansson et al
showed that expression of MMP-13 and MMP-1 in transformed
HK requires p38-MAPK (Johansson et al, 2000). Under similar
conditions, several other groups have shown that hypoxia
stimulates activation of p38-MAPK in a wide range of cell types
(Conrad et al, 1999; Uehara et al, 1999; Kacimi et al, 2000).
Thus, these data collectively suggest that the p38-MAPK
pathway may mediate synthesis of gene products that are
responsible for hypoxia-enhanced keratinocyte motility.
Furthermore, two recent reports showed that the inhibition of
p38-MAPK by SB203580 blocks platelet-derived growth factor
(PDGF) induced mouse endothelial and muscle cell migration
(Hedges et al, 1999; Matsumoto et al, 1999). Hedges et al
further showed that overexpression of dominant-negative p38-
MAPK-a or HSP27, a downstream target for p38-MAPK,
blocked the PDGF-induced human muscle cell migration
(Hedges et al, 1999). Therefore, it would be of great interest
to study if the p38-MAPK pathway plays a common role in the
control of migration in a wide range of cell types.
It is clear that the p38-MAPK cascade is activated by diverse
extracellular signals and involved in a wide variety of cellular
responses. An important question is how the p38-MAPK
pathway interprets the speci®city of the different extracellular
signals. One way to achieve the signaling speci®city is to act in
concert with different parallel signaling pathways, such as JNK,
ERK, and p70S6 kinase pathways. The different signaling
combinations could then result in distinct biologic outcomes
(reviewed by Pawson and Nash, 2000). For example, it has
recently been indicated that p38-MAPK also plays an important
role in the expression of involucrin, a prominent differentiation
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marker for HK (Dashti et al, 2001a; 2001b). In this case, p38-
MAPK (a and b) appears to work in concert with the JNK
pathway, as well as the p38-MAPK-d pathway, to regulate
involucrin gene expression. In contrast, in the migratory HK
under the conditions used (collagen plus serum factors), we
detected no activation of the JNK pathway. Therefore, we
speculate that distinct combinations between p38-MAPK (a and
b) and other parallel signaling pathway(s) determine the ultimate
cellular responses, such as stress gene expression, migration, or
differentiation in HK.
In summary, we have identi®ed for the ®rst time the important
role of the p38-MAPK pathway in HK migration on type I
collagen. Our study also suggests that in order to drive kertinocyte
migration the p38-MAPK pathway needs to work together with
other parallel signaling pathways. Although continued studies are
required for a full understanding of the ultimate signaling
mechanisms in the control of HK motility, this study has identi®ed
one potential cellular target for the treatment of human skin
wounds.
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